Trial Profile
Efficacy, clinical tolerance and main analytical changes of Darunavir/cobicistat plus Lamivudine treatment in patients with HIV infection: a real life study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Dec 2017
Price :
$35
*
At a glance
- Drugs Cobicistat/darunavir (Primary) ; Lamivudine
- Indications HIV infections
- Focus Therapeutic Use
- 06 Dec 2017 New trial record
- 27 Oct 2017 Results presented at the 16th European AIDS Conference